全文获取类型
| 收费全文 | 4131838篇 |
| 免费 | 294136篇 |
| 国内免费 | 17017篇 |
专业分类
| 耳鼻咽喉 | 56795篇 |
| 儿科学 | 133045篇 |
| 妇产科学 | 112603篇 |
| 基础医学 | 586120篇 |
| 口腔科学 | 113850篇 |
| 临床医学 | 385126篇 |
| 内科学 | 793013篇 |
| 皮肤病学 | 94089篇 |
| 神经病学 | 331563篇 |
| 特种医学 | 155922篇 |
| 外国民族医学 | 1211篇 |
| 外科学 | 611922篇 |
| 综合类 | 102064篇 |
| 现状与发展 | 39篇 |
| 一般理论 | 1605篇 |
| 预防医学 | 321715篇 |
| 眼科学 | 96982篇 |
| 药学 | 307834篇 |
| 131篇 | |
| 中国医学 | 13808篇 |
| 肿瘤学 | 223554篇 |
出版年
| 2021年 | 36975篇 |
| 2019年 | 36061篇 |
| 2018年 | 48434篇 |
| 2017年 | 37242篇 |
| 2016年 | 42035篇 |
| 2015年 | 48616篇 |
| 2014年 | 67182篇 |
| 2013年 | 98185篇 |
| 2012年 | 132933篇 |
| 2011年 | 141492篇 |
| 2010年 | 85227篇 |
| 2009年 | 80101篇 |
| 2008年 | 129890篇 |
| 2007年 | 137726篇 |
| 2006年 | 139726篇 |
| 2005年 | 135065篇 |
| 2004年 | 128226篇 |
| 2003年 | 123546篇 |
| 2002年 | 118995篇 |
| 2001年 | 185421篇 |
| 2000年 | 190423篇 |
| 1999年 | 161695篇 |
| 1998年 | 49232篇 |
| 1997年 | 43483篇 |
| 1996年 | 43085篇 |
| 1995年 | 41348篇 |
| 1994年 | 37915篇 |
| 1993年 | 35328篇 |
| 1992年 | 125536篇 |
| 1991年 | 121627篇 |
| 1990年 | 118211篇 |
| 1989年 | 114478篇 |
| 1988年 | 105324篇 |
| 1987年 | 103200篇 |
| 1986年 | 97074篇 |
| 1985年 | 93011篇 |
| 1984年 | 69459篇 |
| 1983年 | 59132篇 |
| 1982年 | 35254篇 |
| 1979年 | 62955篇 |
| 1978年 | 44749篇 |
| 1977年 | 37779篇 |
| 1976年 | 35566篇 |
| 1975年 | 37987篇 |
| 1974年 | 45311篇 |
| 1973年 | 43168篇 |
| 1972年 | 40615篇 |
| 1971年 | 38151篇 |
| 1970年 | 35128篇 |
| 1969年 | 33808篇 |
排序方式： 共有10000条查询结果，搜索用时 32 毫秒
11.
12.
13.
14.
15.
Ian M. Windmill 《中国听力语言康复科学杂志》2015,(1)
随着婴儿潮、人口老龄化及新技术的广泛应用，人们对听力保健的需求显著增加。在美国，听力保健服务由助听设备专员、耳鼻喉科医生和听力师3类人员提供，其中听力师提供除医疗、手术外宽泛的听力保健服务。美国的听力保健服务体系及听力师教育体系经历了一个渐进的过程：20年前对从业人员的学历要求是听力学硕士，随着对服务质量要求的提高和服务范围的扩大，美国听力师逐渐要求专业博士学位（Au.D），毕业后还需3～4年的专门教育才能成为一名听力师。听力师教育有统一的标准，大学课程要通过听力教育认证委员会（the Accreditation Commission for Audiology Education， ACAE）或学术认证委员会（the Council on Academic Accreditation，CAA）的多程序严格的认证才能被承认。美国听力师需求存在巨大缺口，但是各国听力学教育标准不统一及听力师收入与教育投资不匹配，阻碍了更多的人进入这一领域。美国试图通过改变教育模式，降低教育成本及革新教学方法等改善听力师教育状况，但是听力师教育体系远未完善。 相似文献
16.
17.
Accuracy and Precision of Acetabular Component Placement With Imageless Navigation in Obese Patients
Leonard T. Buller Alexander S. McLawhorn Jose A. Romero Peter K. Sculco David J. Mayman 《The Journal of arthroplasty》2019,34(4):693-699
Background
Obesity is a risk factor for acetabular component malposition when total hip arthroplasty is performed with manual techniques. The utility of imageless navigation in obese patients remains unknown. This study compared the accuracy and precision of imageless navigation for component orientation between obese and nonobese patients.Methods
A total of 459 total hip arthroplasties performed for osteoarthritis using imageless navigation were reviewed from a single surgeon’s institutional review board–approved database. Einzel-Bild-Roentgen Analyse determined component orientation on 6-week postoperative anteroposterior radiographs. Mean orientation error (accuracy) and precision were compared between obese (body mass index ≥ 30 kg/m2) and nonobese patients. Regression analysis evaluated the influence of obesity on component position.Results
The difference in mean inclination and anteversion between obese and nonobese groups was 1.1° (43.0° ± 3.5°; range, 35.8°-57.8° vs 41.9° ± 4.4°; range, 33.0°-57.1° and 24.9° ± 6.3°; range, 14.2°-44.3° vs 23.8° ± 6.6°; range, 7.0°-38.6°, respectively). Inclination precision was better for nonobese patients. No difference in inclination accuracy or anteversion accuracy or precision was detected between groups. And 83% of components were placed within the target range. There was no relationship between obesity (dichotomized) and component placement outside the target ranges for inclination, anteversion, or both. As a continuous variable, increased body mass index correlated with higher odds of inclination outside the target zone (odds ratio, 1.06; P = .001).Conclusion
Using imageless navigation, inclination orientation was less precise for obese patients, but the observed difference is likely not clinically relevant. Accurate superficial registration of landmarks in obese patients is achievable, and the use of imageless navigation similarly improves acetabular component positioning in obese and nonobese patients.Level of Evidence
Therapeutic Level IV. 相似文献18.
Jae Eun Choi Tyler Werbel Zhenping Wang Chia Chi Wu Tony L. Yaksh Anna Di Nardo 《Journal of dermatological science》2019,93(1):58-64
Background
Rosacea is a chronic inflammatory skin condition whose etiology has been linked to mast cells and the antimicrobial peptide cathelicidin LL-37. Individuals with refractory disease have demonstrated clinical benefit with periodic injections of onabotulinum toxin, but the mechanism of action is unknown.Objectives
To investigate the molecular mechanism by which botulinum toxin improves rosacea lesions.Methods
Primary human and murine mast cells were pretreated with onabotulinum toxin A or B or control. Mast cell degranulation was evaluated by β-hexosaminidase activity. Expression of botulinum toxin receptor Sv2 was measured by qPCR. The presence of SNAP-25 and VAMP2 was established by immunofluorescence. In vivo rosacea model was established by intradermally injecting LL-37 with or without onabotulinum toxin A pretreatment. Mast cell degranulation was assessed in vivo by histologic counts. Rosacea biomarkers were analyzed by qPCR of mouse skin sections.Results
Onabotulinum toxin A and B inhibited compound 48/80-induced degranulation of both human and murine mast cells. Expression of Sv2 was established in mouse mast cells. Onabotulinum toxin A and B increased cleaved SNAP-25 and decreased VAMP2 staining in mast cells respectively. In mice, injection of onabotulinum toxin A significantly reduced LL-37-induced skin erythema, mast cell degranulation, and mRNA expression of rosacea biomarkers.Conclusions
These findings suggest that onabotulinum toxin reduces rosacea-associated skin inflammation by directly inhibiting mast cell degranulation. Periodic applications of onabotulinum toxin may be an effective therapy for refractory rosacea and deserves further study. 相似文献19.
M. Iachina P.M. Ljungdalh R.G. Sørensen L. Kaerlev J. Blaakær O. Trosko N. Qvist B.M. Nørgård 《Clinical oncology (Royal College of Radiologists (Great Britain))》2019,31(2):115-123
Aims
To examine the influence of pre-existing psychiatric disorder on the choice of treatment in patients with gynaecological cancer.Materials and methods
The analyses were based on all patients who underwent surgical treatment for endometrial, ovarian or cervical cancer who were registered in the Danish Gynecological Cancer Database in the years 2007–2014 (3059 patients with ovarian cancer, 5100 patients with endometrial cancer and 1150 with cervical cancer). Logistic regression model and Cox regression model, adjusted for relevant confounders, were used to estimate the effect of pre-existing psychiatric disorder on the course of cancer treatment. Our outcomes were (i) presurgical oncological treatment, (ii) macroradical surgery for patients with ovarian cancer, (iii) radiation/chemotherapy within 30 days and 100 days after surgery and (iv) time from surgery to first oncological treatment.Results
In the group of patients with ovarian cancer, more patients with a psychiatric disorder received macroradical surgery versus patients without a psychiatric disorder, corresponding to an adjusted odds ratio of 1.24 (95% confidence interval 0.62–2.41) and the chance for having oncological treatment within 100 days was odds ratio = 1.26 (95% confidence interval 0.77–2.10). As for patients with endometrial cancer, all outcome estimates were close to unity. The adjusted odds ratio for oncological treatment within 30 days after surgery in patients with cervical cancer with a history of psychiatric disorder was 0.20 (95% confidence interval 0.03–1.54).Conclusions
We did not find any significant differences in the treatment of ovarian and endometrial cancer in patients with pre-existing psychiatric diagnoses. When it comes to oncological treatment, we suggest that increased attention should be paid to patients with cervical cancer having a pre-existing psychiatric diagnosis. 相似文献20.